Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by Medecinemanon Feb 16, 2016 5:49pm
116 Views
Post# 24563663

More palliative care patients should get medical marijuana

More palliative care patients should get medical marijuana

Canada is in the midst of drawing up guidelines for end-of-life care, but some doctors believe that the medical system isn't doing enough to offer high-quality pain relief to patients, including the option to use medical marijuana.

Though researchers are learning that cannabis can offer many benefits in pain relief, less than 10 per cent of palliative care patients are able to access the drug, in part because of outdated restrictions that make it hard to access, some doctors say.

Less than 10% can access the drug...

“When we have patients with hard-to-treat pain, we have to look at all the modalities we have available to us. Medical cannabis is one of those. So we have to broaden our knowledge and our attempts to help these patients.”

 

Bullboard Posts